{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:29:14Z","timestamp":1792466954124,"version":"4.5.0"},"reference-count":77,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000276","name":"UK Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fleming Fund","award":["R52354 CN001"],"award-info":[{"award-number":["R52354 CN001"]}]},{"DOI":"10.13039\/501100000272","name":"UK National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR305136"],"award-info":[{"award-number":["NIHR305136"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR HealthTech Research"},{"name":"In Vitro Diagnostics"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Antimicrobial resistance (AMR) is a major global health threat, with the greatest burden falling on low- and middle-income countries (LMICs) also challenged with limited surveillance capacity. The UK Government's Fleming Fund was established in 2015 to strengthen AMR surveillance across Africa and Asia through a One Health approach. This paper draws on program experience, country implementation evidence, and published literature to describe how the Fleming Fund operationalized AMR surveillance, assess its contribution to the quantity and quality of surveillance data, identify key implementation challenges, and consider implications for future global surveillance strategies. The Fleming Fund combined investments in laboratory infrastructure, workforce development, quality assurance, data systems, governance, and data use. Across supported countries, these investments enabled substantial growth in routine bacteriology and antimicrobial susceptibility testing, strengthened reference and surveillance laboratory capacity, increased participation in external quality assessment, and expanded reporting to the World Health Organization's Global Antimicrobial Resistance and Use Surveillance System. The program also supported complementary surveillance approaches, including antimicrobial use and consumption data and, in some settings, burden-of-disease and genomic surveillance. Progress, however, has been uneven and remains vulnerable to fragile infrastructure, procurement and supply chain bottlenecks, workforce turnover, fragmented data systems, weak clinical\u2013laboratory interfaces, limited representativeness, and uncertain long-term financing. The Fleming Fund experience shows that strengthening AMR surveillance in LMICs is feasible, but requires sustained, system-wide investment. Future strategies should prioritize integration with clinical care, stronger digital and analytical capacity, broader diagnostic access, and domestic financing to ensure that high-quality AMR data are generated, shared, and translated into action.<\/jats:p>","DOI":"10.1093\/cid\/ciag497","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:29:46Z","timestamp":1792423786000},"page":"S13-S24","source":"Crossref","is-referenced-by-count":4,"title":["Generating Actionable Data From Antimicrobial Resistance Surveillance: Insights From the Fleming Fund's International Experience"],"prefix":"10.1093","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5150-2970","authenticated-orcid":false,"given":"Ankur","family":"Gupta-Wright","sequence":"first","affiliation":[{"name":"Department of Infectious Disease, Imperial College London , London ,","place":["United Kingdom"]},{"name":"Department of Infectious Diseases and Tropical Medicine, Heidelberg University Hospital , Heidelberg ,","place":["Germany"]},{"name":"Department of Infectious Diseases, Bristol NHS Foundation Trust , Bristol ,","place":["United Kingdom"]},{"name":"Itad Ltd, Brighton ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suliat Yetunde","family":"Adeleke","sequence":"additional","affiliation":[{"name":"Federal Ministry of Livestock Development , Abuja ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6302-1798","authenticated-orcid":false,"given":"Victoria","family":"Adetunji","sequence":"additional","affiliation":[{"name":"Department of Veterinary Public Health and Preventive Medicine, University of Ibadan , Ibadan ,","place":["Nigeria"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qadeer","family":"Ahsan","sequence":"additional","affiliation":[{"name":"DAI Global LLC , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Amatya","sequence":"additional","affiliation":[{"name":"FHI 360 , Kathmandu ,","place":["Nepal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8569-1650","authenticated-orcid":false,"given":"Ben","family":"Amos","sequence":"additional","affiliation":[{"name":"Independent consultant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2216-501X","authenticated-orcid":false,"given":"Brian","family":"Asare","sequence":"additional","affiliation":[{"name":"Ministry of Health Pharmacy Directorate, , Accra ,","place":["Ghana"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorie I O","family":"Bangura","sequence":"additional","affiliation":[{"name":"Ministry of Health and Sanitation , Freetown ,","place":["Sierra Leone"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Buhler","sequence":"additional","affiliation":[{"name":"ORDiagnostics ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4041-1405","authenticated-orcid":false,"given":"Nicholas","family":"Feasey","sequence":"additional","affiliation":[{"name":"University of St Andrews The School of Medicine, , St Andrews ,","place":["United Kingdom"]},{"name":"Liverpool School of Tropical Medicine Department of Clinical Sciences, , Liverpool ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N Claire","family":"Gordon","sequence":"additional","affiliation":[{"name":"UK Health Security Agency , Porton Down, Salisbury ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Hopkins","sequence":"additional","affiliation":[{"name":"Mott MacDonald Fleming Fund , International Development Sector, , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-9572","authenticated-orcid":false,"given":"Freddy Eric","family":"Kitutu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, School of Health Sciences, Makerere University College of Health Sciences , Kampala ,","place":["Uganda"]},{"name":"Uppsala University Department of Women\u2019s and Children\u2019s Health, International Child Health and Migration, , Uppsala ,","place":["Sweden"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toby","family":"Leslie","sequence":"additional","affiliation":[{"name":"Mott MacDonald Fleming Fund , International Development Sector, , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahima","family":"Lo","sequence":"additional","affiliation":[{"name":"Food and Agriculture Organization of the United Nations , Dakar ,","place":["Senegal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seynabou","family":"Lo","sequence":"additional","affiliation":[{"name":"UFR des Sciences de la Sant\u00e9, Universit\u00e9 Gaston Berger de Saint-Louis , Saint-Louis ,","place":["Senegal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayodele","family":"Majekodunmi","sequence":"additional","affiliation":[{"name":"Ajisefini Consulting , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8900-2138","authenticated-orcid":false,"given":"Rebecca","family":"Maudling","sequence":"additional","affiliation":[{"name":"Itad Ltd, Brighton ,","place":["United Kingdom"]},{"name":"Independent consultant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ntombi B","family":"Mudenda","sequence":"additional","affiliation":[{"name":"Department of Clinical Studies, School of Veterinary Medicine, University of Zambia , Lusaka ,","place":["Zambia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-2784","authenticated-orcid":false,"given":"Victor Moses","family":"Musyoki","sequence":"additional","affiliation":[{"name":"Burnet Institute , Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Nanjebe","sequence":"additional","affiliation":[{"name":"Mott MacDonald Fleming Fund , International Development Sector, , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Oakley","sequence":"additional","affiliation":[{"name":"Menzies School of Health Research, Charles Darwin University Global and Tropical Health Division, , Darwin, Northern Territory ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5929-9974","authenticated-orcid":false,"given":"Manish","family":"Pathak","sequence":"additional","affiliation":[{"name":"Mott MacDonald Fleming Fund , International Development Sector, , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8599-737X","authenticated-orcid":false,"given":"Tamalee","family":"Roberts","sequence":"additional","affiliation":[{"name":"Mahosot Hospital Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, , Vientiane , Lao People's Democratic Republic"},{"name":"University of Oxford Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, , Oxford ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0335-814X","authenticated-orcid":false,"given":"Lamiaa","family":"Shehata","sequence":"additional","affiliation":[{"name":"Itad Ltd, Brighton ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0792-660X","authenticated-orcid":false,"given":"Tim","family":"Shorten","sequence":"additional","affiliation":[{"name":"Itad Ltd, Brighton ,","place":["United Kingdom"]},{"name":"Independent consultant"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nure Alam","family":"Siddiky","sequence":"additional","affiliation":[{"name":"DAI Global LLC , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Stelling","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Brigham and Women\u2019s Hospital, Boston, Massachusetts ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Taimoor","sequence":"additional","affiliation":[{"name":"DAI Global LLC , Bethesda, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"May Soe","family":"Thwe","sequence":"additional","affiliation":[{"name":"Fondation M\u00e9rieux , Vientiane ,","place":["Lao People's Democratic Republic"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7047-3063","authenticated-orcid":false,"given":"Shawn","family":"Ting","sequence":"additional","affiliation":[{"name":"Menzies School of Health Research, Charles Darwin University Global and Tropical Health Division, , Darwin, Northern Territory ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didem","family":"Torumkuney","sequence":"additional","affiliation":[{"name":"GSK , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1013-7815","authenticated-orcid":false,"given":"Paul","family":"Turner","sequence":"additional","affiliation":[{"name":"University of Oxford Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, , Oxford ,","place":["United Kingdom"]},{"name":"Cambodia Oxford Medical Research Unit, Angkor Hospital for Children , Siem Reap ,","place":["Cambodia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Wildfire","sequence":"additional","affiliation":[{"name":"Mott MacDonald Fleming Fund , International Development Sector, , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy David","family":"Worth","sequence":"additional","affiliation":[{"name":"Mott MacDonald Fleming Fund , International Development Sector, , London ,","place":["United Kingdom"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,10,19]]},"reference":[{"key":"2026101911293988000_ciag497-B1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103384","article-title":"The prevalence and risk of mortality associated with antimicrobial resistance within nosocomial settings\u2014a global systematic review and meta-analysis of over 20,000 patients","volume":"87","author":"George","year":"2025","journal-title":"EClinicalMedicine"},{"key":"2026101911293988000_ciag497-B2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004199","article-title":"The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: a systematic review and meta-analysis","volume":"20","author":"Allel","year":"2023","journal-title":"PLoS Med"},{"key":"2026101911293988000_ciag497-B3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004262","article-title":"Understanding the impact of antimicrobial resistance on outcomes of bloodstream infections in low- and middle-income countries","volume":"20","author":"de Kraker","year":"2023","journal-title":"PLoS Med"},{"key":"2026101911293988000_ciag497-B4","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(24)01885-3","article-title":"Global burden of antimicrobial resistance and forecasts to 2050","volume":"404","author":"Kariuki","year":"2024","journal-title":"Lancet"},{"key":"2026101911293988000_ciag497-B5","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/S0140-6736(24)01867-1","article-title":"Global burden of bacterial antimicrobial resistance 1990\u20132021: a systematic analysis with forecasts to 2050","volume":"404","author":"GBD 2021 Antimicrobial Resistance Collaborators","year":"2024","journal-title":"Lancet"},{"key":"2026101911293988000_ciag497-B6","first-page":"S3","article-title":"The Fleming Fund: key features of design and approach to strengthening antimicrobial resistance surveillance in low- and middle-income countries","volume":"83","author":"Shorten","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911293988000_ciag497-B7","author":"UN. General Assembly. President, UN"},{"key":"2026101911293988000_ciag497-B8","volume-title":"Antimicrobial resistance: global report on surveillance","author":"World Health Organization","year":"2014"},{"key":"2026101911293988000_ciag497-B9","author":"World Health Organization"},{"key":"2026101911293988000_ciag497-B10"},{"key":"2026101911293988000_ciag497-B11","doi-asserted-by":"crossref","first-page":"92","DOI":"10.12688\/wellcomeopenres.12527.1","article-title":"AMR Surveillance in low and middle-income settings\u2014a roadmap for participation in the Global Antimicrobial Surveillance System (GLASS)","volume":"2","author":"Seale","year":"2017","journal-title":"Wellcome Open Res"},{"key":"2026101911293988000_ciag497-B12","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fmed.2020.00258","article-title":"Editorial: clinical microbiology in low resource settings","volume":"7","author":"Kozlakidis","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"2026101911293988000_ciag497-B13","first-page":"S37","article-title":"Antimicrobial resistance and one health: lessons on one health governance and implementation from the Fleming fund","volume":"83","author":"Abbas","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911293988000_ciag497-B14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.100976","article-title":"Bacteriology testing and antimicrobial resistance detection capacity of national tiered laboratory networks in sub-Saharan Africa: an analysis from 14 countries","volume":"6","author":"Ondoa","year":"2025","journal-title":"Lancet Microbe"},{"key":"2026101911293988000_ciag497-B15","doi-asserted-by":"crossref","first-page":"S588","DOI":"10.1093\/cid\/ciad569","article-title":"Evaluating quality management and diagnostics microbiology performance within an international external quality assessment (EQA) program serving national one health sector reference laboratories across Asia: experience amid the coronavirus disease 2019 (COVID-19) pandemic","volume":"77","author":"Abegaz","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026101911293988000_ciag497-B16","doi-asserted-by":"crossref","first-page":"S581","DOI":"10.1093\/cid\/ciad487","article-title":"Key recommendations for antimicrobial resistance surveillance: takeaways from the CAPTURA project","volume":"77","author":"Aboushady","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2026101911293988000_ciag497-B17","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/jac\/dkaf266","article-title":"Strengthening antimicrobial resistance diagnostics in National Reference Laboratories across One Health in South and Southeast Asia: impact of external quality assessment and targeted follow-up","volume":"80","author":"Abegaz","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026101911293988000_ciag497-B18","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.1093\/clinids\/24.Supplement_1.S157","article-title":"Surveillance of antimicrobial resistance: the WHONET program","volume":"24 Suppl 1","author":"Stelling","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2026101911293988000_ciag497-B19","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0377-1237(09)80020-8","article-title":"WHONET software for the surveillance of antimicrobial susceptibility","volume":"65","author":"Agarwal","year":"2009","journal-title":"Med J Armed Forces India"},{"key":"2026101911293988000_ciag497-B20","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-078504","article-title":"Implementation of an antibiotic resistance surveillance tool in Madagascar, the TSARA project: a prospective, observational, multicentre, hospital-based study protocol","volume":"14","author":"Elias","year":"2024","journal-title":"BMJ Open"},{"key":"2026101911293988000_ciag497-B21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.12688\/wellcomeopenres.19210.1","article-title":"ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance","volume":"8","author":"Mo","year":"2023","journal-title":"Wellcome Open Res"},{"key":"2026101911293988000_ciag497-B22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12688\/wellcomeopenres.15681.1","article-title":"ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network): a pilot protocol for case based antimicrobial resistance surveillance","volume":"5","author":"Turner","year":"2020","journal-title":"Wellcome Open Res"},{"key":"2026101911293988000_ciag497-B23","doi-asserted-by":"crossref","first-page":"309","DOI":"10.12688\/wellcomeopenres.18317.1","article-title":"A Clinically Oriented antimicrobial Resistance surveillance Network (ACORN): pilot implementation in three countries in Southeast Asia, 2019-2020","volume":"7","author":"van Doorn","year":"2022","journal-title":"Wellcome Open Res"},{"key":"2026101911293988000_ciag497-B24","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/s41564-021-00870-7","article-title":"Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries","volume":"6","author":"Sands","year":"2021","journal-title":"Nat Microbiol"},{"key":"2026101911293988000_ciag497-B25","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2025.101228","article-title":"Prospective characterisation of drug-resistant bloodstream infections in Africa and Asia (ACORN2): a surveillance network assessment","volume":"7","author":"Hopkins","year":"2026","journal-title":"Lancet Microbe"},{"key":"2026101911293988000_ciag497-B26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/dkac342","article-title":"Systematic review of surveillance systems for AMR in Africa","volume":"78","author":"Okolie","year":"2023","journal-title":"J Antimicrob Chemother"},{"key":"2026101911293988000_ciag497-B27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.12688\/wellcomeopenres.23133.1","article-title":"Progress on implementing the WHO-GLASS recommendations on priority pathogen-antibiotic sensitivity testing in Africa: a scoping review","volume":"9","author":"Hope","year":"2024","journal-title":"Wellcome Open Res"},{"key":"2026101911293988000_ciag497-B28","author":"Itad"},{"key":"2026101911293988000_ciag497-B29","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/S1473-3099(17)30394-8","article-title":"Trends in antimicrobial resistance in bloodstream infection isolates at a large urban hospital in Malawi (1998-2016): a surveillance study","volume":"17","author":"Musicha","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"2026101911293988000_ciag497-B30","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3201\/eid0702.010235","article-title":"Building communication networks: international network for the study and prevention of emerging antimicrobial resistance","volume":"7","author":"Richet","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"2026101911293988000_ciag497-B31","author":"UKCDR"},{"key":"2026101911293988000_ciag497-B32","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1093\/jac\/dky026","article-title":"An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000","volume":"73","author":"Ashley","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"2026101911293988000_ciag497-B33","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1017\/ash.2022.47","article-title":"Antimicrobial stewardship in Latin America: past, present, and future","volume":"2","author":"Fabre","year":"2022","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"2026101911293988000_ciag497-B34","article-title":"Response to antimicrobial resistance in South-East Asia region","volume":"18","author":"Sihombing","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"2026101911293988000_ciag497-B35","doi-asserted-by":"crossref","first-page":"164","DOI":"10.4103\/ijmr.IJMR_226_18","article-title":"Establishing antimicrobial resistance surveillance & research network in India: journey so far","volume":"149","author":"Walia","year":"2019","journal-title":"Indian J Med Res"},{"key":"2026101911293988000_ciag497-B36","doi-asserted-by":"crossref","DOI":"10.1093\/jacamr\/dlae052","article-title":"Antimicrobial resistance of clinical bacterial isolates in China: current status and trends","volume":"6","author":"Qin","year":"2024","journal-title":"JAC Antimicrob Resist"},{"key":"2026101911293988000_ciag497-B37","doi-asserted-by":"crossref","first-page":"e1186","DOI":"10.1016\/S2214-109X(17)30370-4","article-title":"Developing an antimicrobial resistance reference laboratory and surveillance programme in Vietnam","volume":"5","author":"Kinh","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2026101911293988000_ciag497-B38","author":"NICD"},{"key":"2026101911293988000_ciag497-B39","volume-title":"The International FAO Antimicrobial Resistance Monitoring (InFARM) system and IT platform","author":"FAO","year":"2022"},{"key":"2026101911293988000_ciag497-B40","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jac\/dkaf032","article-title":"External quality assurance (EQA) network in South and South-East Asia: experience and results from an international EQA programme in One Health sector reference laboratories","volume":"80","author":"Kostyanev","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026101911293988000_ciag497-B41","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jiac.2020.08.007","article-title":"Genetic analysis of ESBL-producing Klebsiella pneumoniae isolated from UTI patients in Indonesia","volume":"27","author":"Yamasaki","year":"2021","journal-title":"J Infect Chemother"},{"key":"2026101911293988000_ciag497-B42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.ijantimicag.2017.11.012","article-title":"Insertion sequence transpositions and point mutations in mgrB causing colistin resistance in a clinical strain of carbapenem-resistant Klebsiella pneumoniae from Vietnam","volume":"51","author":"Berglund","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"2026101911293988000_ciag497-B43","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jac\/dky506","article-title":"Limited contribution of non-intensive chicken farming to ESBL-producing Escherichia coli colonization in humans in Vietnam: an epidemiological and genomic analysis","volume":"74","author":"Nguyen","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026101911293988000_ciag497-B44","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/jac\/dkv021","article-title":"Colonization with Enterobacteriaceae producing ESBLs in children attending pre-school childcare facilities in the Lao People's Democratic Republic","volume":"70","author":"Stoesser","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"2026101911293988000_ciag497-B45","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3934\/microbiol.2023013","article-title":"Extended spectrum beta lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae in Indonesia and South East Asian countries: GLASS Data 2018","volume":"9","author":"Sunarno","year":"2023","journal-title":"AIMS Microbiol"},{"key":"2026101911293988000_ciag497-B46","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1186\/s12879-026-12931-5","article-title":"Prevalence, trend and resistance patterns of carbapenem-resistant enterobacterales in Bangladesh: a nationwide laboratory-based study","volume":"26","author":"Rahman","year":"2026","journal-title":"BMC Infect Dis"},{"key":"2026101911293988000_ciag497-B47","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3390\/antibiotics13020120","article-title":"Prevalence of antimicrobial resistance in Escherichia coli and Salmonella species isolates from chickens in live bird markets and boot swabs from layer farms in Timor-Leste","volume":"13","author":"Pereira","year":"2024","journal-title":"Antibiotics (Basel)"},{"key":"2026101911293988000_ciag497-B48","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.3390\/antibiotics11091262","article-title":"Gastrointestinal carriage of antimicrobial resistance in school-aged children in three municipalities of Timor-Leste","volume":"11","author":"Oakley","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026101911293988000_ciag497-B49","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0140-6736(22)02185-7","article-title":"Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the global burden of disease study 2019","volume":"400","author":"Ikuta","year":"2022","journal-title":"Lancet"},{"key":"2026101911293988000_ciag497-B50","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/cid\/ciag520","article-title":"Surveillance data use through the Fleming Fund: informing action on Antimicrobial Resistance in low- and middle-income countries","volume":"83","author":"Drake","year":"2026","journal-title":"Clin Infect Dis"},{"key":"2026101911293988000_ciag497-B51","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.cmi.2021.05.037","article-title":"Surveillance strategies using routine microbiology for antimicrobial resistance in low- and middle-income countries","volume":"27","author":"Lim","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2026101911293988000_ciag497-B52","author":"Dacombe"},{"key":"2026101911293988000_ciag497-B53","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5334\/aogh.3416","article-title":"Strengthening antimicrobial resistance diagnostic capacity in rural Rwanda: a feasibility assessment","volume":"87","author":"Umutesi","year":"2021","journal-title":"Ann Glob Health"},{"key":"2026101911293988000_ciag497-B54","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jhin.2024.03.014","article-title":"Assessment of antimicrobial resistance laboratory-based surveillance capacity of hospitals in Zambia: findings and implications for system strengthening","volume":"148","author":"Yamba","year":"2024","journal-title":"J Hosp Infect"},{"key":"2026101911293988000_ciag497-B55","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/antibiotics11040427","article-title":"Antimicrobial susceptibility testing: a comprehensive review of currently used methods","volume":"11","author":"Gajic","year":"2022","journal-title":"Antibiotics (Basel)"},{"key":"2026101911293988000_ciag497-B56","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.3390\/antibiotics14111136","article-title":"Diagnostic stewardship trends and antimicrobial resistance profiles of bacteria isolated in Zambia: a five-year retrospective study (2020\u20132024)","volume":"14","author":"Chizimu","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"2026101911293988000_ciag497-B57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13756-021-00931-w","article-title":"Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture","volume":"10","author":"Iskandar","year":"2021","journal-title":"Antimicrob Resist Infect Control"},{"key":"2026101911293988000_ciag497-B58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000018","article-title":"Antimicrobial resistance detection in Southeast Asian hospitals is critically important from both patient and societal perspectives, but what is its cost?","volume":"1","author":"Roberts","year":"2021","journal-title":"PLoS Global Public Health"},{"key":"2026101911293988000_ciag497-B59","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1128\/JCM.00833-15","article-title":"Cost savings realized by implementation of routine microbiological identification by matrix-assisted laser desorption ionization\u2013time of flight mass spectrometry","volume":"53","author":"Tran","year":"2015","journal-title":"J Clin Microbiol"},{"key":"2026101911293988000_ciag497-B60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3390\/diagnostics9010010","article-title":"Defining system requirements for simplified blood culture to enable widespread use in resource-limited settings","volume":"9","author":"Dailey","year":"2019","journal-title":"Diagnostics (Basel)"},{"key":"2026101911293988000_ciag497-B61","author":"Worth"},{"key":"2026101911293988000_ciag497-B62","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2025.1607013","article-title":"Building capacities in Sub-Saharan African countries for antimicrobial resistance surveillance in the food and agriculture sectors using the FAO ATLASS tool","volume":"12","author":"Ouoba","year":"2025","journal-title":"Front Vet Sci"},{"key":"2026101911293988000_ciag497-B63","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s42522-025-00192-2","article-title":"Assessing the antimicrobial resistance testing capacity of public and private veterinary laboratories in Kenya","volume":"8","author":"Morang\u2019a","year":"2026","journal-title":"One Health Outlook"},{"key":"2026101911293988000_ciag497-B64","author":"Optimising AMR surveillance in animal health"},{"key":"2026101911293988000_ciag497-B65","doi-asserted-by":"crossref","DOI":"10.3389\/frabi.2023.1233698","article-title":"Antimicrobial resistance interventions in the animal sector: scoping review","volume":"2","author":"Jacobsen","year":"2023","journal-title":"Front Antibiot"},{"key":"2026101911293988000_ciag497-B66","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12889-020-8319-3","article-title":"The challenges of investigating antimicrobial resistance in Vietnam\u2014what benefits does a One Health approach offer the animal and human health sectors?","volume":"20","author":"Mitchell","year":"2020","journal-title":"BMC Public Health"},{"key":"2026101911293988000_ciag497-B67","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1016\/S1473-3099(24)00649-2","article-title":"Sustainable antimicrobial resistance surveillance: time for a global funding mechanism","volume":"25","author":"Painter","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"2026101911293988000_ciag497-B68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3390\/antibiotics15010103","article-title":"Understanding the financial implications of antimicrobial resistance surveillance in Nepal: context-specific evidence for policy and sustainable financing strategies","volume":"15","author":"Yum","year":"2026","journal-title":"Antibiotics"},{"key":"2026101911293988000_ciag497-B69","doi-asserted-by":"crossref","first-page":"e308","DOI":"10.1016\/S1473-3099(25)00662-0","article-title":"Transitioning to people-centred antimicrobial resistance surveillance","volume":"26","author":"Limmathurotsakul","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"2026101911293988000_ciag497-B70","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0140-6736(21)00673-5","article-title":"The Lancet Commission on diagnostics: transforming access to diagnostics","volume":"398","author":"Fleming","year":"2021","journal-title":"Lancet"},{"key":"2026101911293988000_ciag497-B71","doi-asserted-by":"crossref","first-page":"e181","DOI":"10.1016\/S1473-3099(25)00313-5","article-title":"Artificial intelligence and infectious diseases: tackling antimicrobial resistance, from personalised care to antibiotic discovery","volume":"26","author":"Howard","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"2026101911293988000_ciag497-B72","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1716498","article-title":"Seqafrica: empowering Africa's fight against antimicrobial resistance through genomics","volume":"13","author":"Nilsson","year":"2025","journal-title":"Front Public Health"},{"key":"2026101911293988000_ciag497-B73","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-002244","article-title":"Whole-genome sequencing as part of national and international surveillance programmes for antimicrobial resistance: a roadmap","volume":"5","author":"NIHR Global Health Research Unit on Genomic Surveillance of AMR","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2026101911293988000_ciag497-B74","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-003622","article-title":"Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings","volume":"5","author":"Okeke","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2026101911293988000_ciag497-B75","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2991\/dsahmj.k.190225.001","article-title":"Essential diagnostics: a key element of universal health coverage","volume":"1","author":"Pai","year":"2019","journal-title":"Dr Sulaiman Al Habib Med J"},{"key":"2026101911293988000_ciag497-B76","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.cmi.2022.05.006","article-title":"Unbiased antimicrobial resistance prevalence estimates through population-based surveillance","volume":"29","author":"van Leth","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"2026101911293988000_ciag497-B77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004265","article-title":"Antimicrobial resistance: strengthening surveillance for public health action","volume":"20","author":"Bertagnolio","year":"2023","journal-title":"PLoS Med"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/Supplement_1\/S13\/72114879\/ciag497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/83\/Supplement_1\/S13\/72114879\/ciag497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:29:55Z","timestamp":1792423795000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/83\/Supplement_1\/S13\/8943555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,15]]},"references-count":77,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2026,10,19]]},"published-print":{"date-parts":[[2026,10,19]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciag497","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,15]]},"published":{"date-parts":[[2026,10,15]]}}}